Kiora Pharmaceuticals Inc
KPRX· Nasdaq
KPRXKiora Pharmaceuticals Inc
Quarterly figures for Kiora Pharmaceuticals Inc, with source filings when available.
50 quarters. Mar 31, 2014 to Jun 30, 2026. USD.
Kiora Pharmaceuticals Inc has filed its 10-Q within 38 to 40 days of period end across its last 8 quarters. The 10-K runs 60 to 105 days.
Kiora Pharmaceuticals Inc · CIK 1372514 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 7, 2026 · pre-market | Aug 7, 2026 | 38 d | 10-Q | — | — | -$0.34 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 8, 2026 · pre-market |
| May 8, 2026 |
| 38 d |
| 10-Q |
| — |
| — |
| -$0.58 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Mar 25, 2026 · pre-market | Mar 25, 2026 | 84 d | 10-K | $0.00 | — | — | |
| Q3 2025 | Sep 30, 2025 | Nov 7, 2025 · pre-market | Nov 7, 2025 | 38 d | 10-Q | $0.00 | — | $0.01 | |
| Q2 2025 | Jun 30, 2025 | Aug 8, 2025 · pre-market | Aug 8, 2025 | 39 d | 10-Q | $0.00 | −100.0% | -$0.54 | |
| Q1 2025 | Mar 31, 2025 | May 9, 2025 · pre-market | May 9, 2025 | 39 d | 10-Q | $0.00 | −100.0% | -$0.52 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Mar 25, 2025 · pre-market | Mar 25, 2025 | 84 d | 10-K | $0.00 | — | — | |
| Q3 2024 | Sep 30, 2024 | Nov 8, 2024 · pre-market | Nov 8, 2024 | 39 d | 10-Q | $0.00 | — | -$0.81 | |
| Q2 2024 | Jun 30, 2024 | Aug 9, 2024 · pre-market | Aug 9, 2024 | 40 d | 10-Q | $20.00K | — | -$0.53 | |
| Q1 2024 | Mar 31, 2024 | May 10, 2024 · pre-market | May 10, 2024 | 40 d | 10-Q | $16.00M | — | $3.46 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Mar 25, 2024 · pre-market | Mar 25, 2024 | 85 d | 10-K | $0.00 | — | — | |
| Q3 2023 | Sep 30, 2023 | Nov 9, 2023 · pre-market | Nov 9, 2023 | 40 d | 10-Q | $0.00 | — | -$7.30 | |
| Q2 2023 | Jun 30, 2023 | Aug 8, 2023 · pre-market | Aug 8, 2023 | 39 d | 10-Q | $0.00 | — | -$7.15 | |
| Q1 2023 | Mar 31, 2023 | May 9, 2023 · pre-market | May 9, 2023 | 39 d | 10-Q | $0.00 | — | -$1.00 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Mar 23, 2023 · pre-market | Mar 23, 2023 | 82 d | 10-K | — | — | — | |
| Q3 2022 | Sep 30, 2022 | — | Nov 9, 2022 | 40 d | 10-Q | — | — | -$6.03 | |
| Q2 2022 | Jun 30, 2022 | — | Aug 12, 2022 | 43 d | 10-Q | — | — | -$0.18 | |
| Q1 2022 | Mar 31, 2022 | — | Jul 8, 2022 | 99 d | 10-Q | — | — | -$11.27 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | — | Apr 15, 2022 | 105 d | 10-K | — | — | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 15, 2021 | 46 d | 10-Q | — | — | -$11.34 | |
| Q2 2021 | Jun 30, 2021 | — | Aug 12, 2021 | 43 d | 10-Q | — | — | -$0.34 | |
| Q1 2021 | Mar 31, 2021 | — | May 12, 2021 | 42 d | 10-Q | — | — | -$0.27 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | — | Mar 25, 2021 | 84 d | 10-K | $12.06K | — | — | |
| Q3 2020 | Sep 30, 2020 | — | Nov 9, 2020 | 40 d | 10-Q | $0.00 | — | -$0.44 | |
| Q2 2020 | Jun 30, 2020 | — | Aug 6, 2020 | 37 d | 10-Q | $0.00 | — | -$0.38 | |
| Q1 2020 | Mar 31, 2020 | — | May 6, 2020 | 36 d | 10-Q | $0.00 | −100.0% | -$0.43 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019derived | Dec 31, 2019 | — | Mar 4, 2020 | 64 d | 10-K | $0.00 | — | — | |
| Q3 2019 | Sep 30, 2019 | — | Nov 7, 2019 | 38 d | 10-Q | $0.00 | −100.0% | -$1.15 | |
| Q2 2019 | Jun 30, 2019 | — | Aug 8, 2019 | 39 d | 10-Q | $0.00 | −100.0% | -$0.63 | |
| Q1 2019 | Mar 31, 2019 | — | May 8, 2019 | 38 d | 10-Q | $2.69M | +145.1% | $0.19 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018derived | Dec 31, 2018 | — | Mar 1, 2019 | 60 d | 10-K | $0.00 | — | — | |
| Q3 2018 | Sep 30, 2018 | — | Nov 13, 2018 | 44 d | 10-Q | $314.50K | +321.0% | -$1.08 | |
| Q2 2018 | Jun 30, 2018 | — | Aug 3, 2018 | 34 d | 10-Q | $242.01K | +63.2% | -$0.07 | |
| Q1 2018 | Mar 31, 2018 | — | May 11, 2018 | 41 d | 10-Q | $1.10M | +493.9% | -$0.14 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017derived | Dec 31, 2017 | — | Mar 2, 2018 | 61 d | 10-K | $0.00 | −100.0% | — | |
| Q3 2017 | Sep 30, 2017 | — | Nov 14, 2017 | 45 d | 10-Q | $74.70K | −72.8% | -$0.24 | |
| Q2 2017 | Jun 30, 2017 | — | Aug 4, 2017 | 35 d | 10-Q | $148.29K | −36.8% | -$0.28 | |
| Q1 2017 | Mar 31, 2017 | — | May 5, 2017 | 35 d | 10-Q | $184.53K | — | -$0.28 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016derived | Dec 31, 2016 | — | Feb 23, 2017 | 54 d | 10-K | $160.37K | — | — | |
| Q3 2016 | Sep 30, 2016 | — | Nov 1, 2016 | 32 d | 10-Q | $274.29K | — | -$0.36 | |
| Q2 2016 | Jun 30, 2016 | — | Aug 10, 2016 | 41 d | 10-Q | $234.60K | — | -$0.46 | |
| Q1 2016 | Mar 31, 2016 | — | May 13, 2016 | 43 d | 10-Q | $0.00 | — | -$0.31 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015derived | Dec 31, 2015 | — | Mar 30, 2016 | 90 d | 10-K | — | — | — | |
| Q3 2015 | Sep 30, 2015 | — | Nov 12, 2015 | 43 d | 10-Q | $0.00 | — | -$0.19 | |
| Q2 2015 | Jun 30, 2015 | — | Aug 12, 2015 | 43 d | 10-Q | $0.00 | — | -$0.24 | |
| Q1 2015 | Mar 31, 2015 | — | May 15, 2015 | 45 d | 10-Q | — | — | -$3.23 | |
| FY 2014 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2014derived | Dec 31, 2014 | — | Mar 31, 2015 | 90 d | 10-K | — | — | — | |
| Q3 2014 | Sep 30, 2014 | — | — | — | — | — | — | $1.59 | |
| Q2 2014 | Jun 30, 2014 | — | — | — | — | — | — | -$3.82 | |
| Q1 2014 | Mar 31, 2014 | — | — | — | — | — | — | -$0.47 | |
